Acurx Pharmaceuticals, Inc.·4

Jan 8, 4:30 PM ET

DELUCCIA ROBERT J 4

4 · Acurx Pharmaceuticals, Inc. · Filed Jan 8, 2025

Insider Transaction Report

Form 4
Period: 2025-01-06
DELUCCIA ROBERT J
Director10% Owner
Transactions
  • Purchase

    Warrants for Common Stock

    2025-01-06+49,26149,261 total
    Exercise: $0.90From: 2025-01-07Exp: 2030-01-07Common Stock (49,261 underlying)
  • Purchase

    Common Stock

    2025-01-06$1.01/sh+49,261$50,0001,010,196 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    3,847
Footnotes (2)
  • [F1]Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
  • [F2]Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.

Documents

1 file
  • 4
    tm252665-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT